Quantification of Blood Caffeine Levels in Patients With Parkinson's Disease and Multiple System Atrophy by Caffeine ELISA

Caffeine is considered to be a neuroprotective agent against Parkinson's disease (PD) and is expected to offer a blood-based biomarker for the disease. We herein investigated the ability of this biomarker to discriminate between PD and neurodegenerative diseases. To quantify caffeine concentrat...

詳細記述

保存先:
書誌詳細
出版年:Front Neurol
主要な著者: Ohmichi, Takuma, Kasai, Takashi, Shinomoto, Makiko, Matsuura, Jun, Koizumi, Takashi, Kitani-Morii, Fukiko, Tatebe, Harutsugu, Sasaki, Hidenao, Mizuno, Toshiki, Tokuda, Takahiko
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2020
主題:
Neurology
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7783046/
https://ncbi.nlm.nih.gov/pubmed/33414755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.580127
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料